Literature DB >> 20170086

Parallel synthesis of an oligomeric imidazole-4,5-dicarboxamide library.

Zhigang Xu1, John C DiCesare, Paul W Baures.   

Abstract

A library of oligomeric compounds was synthesized based on the imidazole-4,5-dicarboxylic acid scaffold along with amino acid esters and chiral diamines derived from amino acids. The final compounds incorporate nonpolar amino acids (Leu, Phe, Trp), polar amino acids (Ser, Asp, Arg), and neutral amino acids (Gly, Ala), and were designed to be useful in screening for inhibitors of protein-protein interactions. Many of the protected and deprotected oligomers show evidence of conformational isomers persistent at room temperature in aqueous solution. A total of 317 final oligomers, out of 441 targeted compounds, were obtained in high analytical purity and of sufficient quantity to submit them for high-throughput screening as part of the NIH Roadmap.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170086      PMCID: PMC2846700          DOI: 10.1021/cc1000105

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  31 in total

Review 1.  Drug-like properties and the causes of poor solubility and poor permeability.

Authors:  C A Lipinski
Journal:  J Pharmacol Toxicol Methods       Date:  2000 Jul-Aug       Impact factor: 1.950

2.  The total synthesis and stereochemical revision of yanucamide A.

Authors:  Zhengshuang Xu; Yungui Peng; Tao Ye
Journal:  Org Lett       Date:  2003-08-07       Impact factor: 6.005

Review 3.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

4.  Insertion of an aspartic acid moiety into cyclic pseudopeptides: synthesis and biological characterization of potent antagonists for the human Tachykinin NK-2 receptor.

Authors:  Valentina Fedi; Maria Altamura; Giuseppe Balacco; Franca Canfarini; Marco Criscuoli; Danilo Giannotti; Alessandro Giolitti; Sandro Giuliani; Antonio Guidi; Nicholas J S Harmat; Rossano Nannicini; Franco Pasqui; Riccardo Patacchini; Enzo Perrotta; Manuela Tramontana; Antonio Triolo; Carlo Alberto Maggi
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

5.  The atomic structure of protein-protein recognition sites.

Authors:  L Lo Conte; C Chothia; J Janin
Journal:  J Mol Biol       Date:  1999-02-05       Impact factor: 5.469

6.  Comparison of protein-protein interactions in serine protease-inhibitor and antibody-antigen complexes: implications for the protein docking problem.

Authors:  R M Jackson
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

7.  Small molecule inhibition of hepatitis C virus E2 binding to CD81.

Authors:  Scott E VanCompernolle; Alexander V Wiznycia; Jeremy R Rush; Muthu Dhanasekaran; Paul W Baures; Scott C Todd
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

8.  Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.

Authors:  Christian A Olsen; M Reza Ghadiri
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

9.  An improved method for the synthesis of dissymmetric N,N'-disubstituted imidazole-4,5-dicarboxamides.

Authors:  Alexander V Wiznycia; Paul W Baures
Journal:  J Org Chem       Date:  2002-10-04       Impact factor: 4.354

10.  Synthesis of symmetric bis(imidazole-4,5-dicarboxamides) substituted with amino acids.

Authors:  Alexander V Wiznycia; Jeremy R Rush; Paul W Baures
Journal:  J Org Chem       Date:  2004-11-26       Impact factor: 4.354

View more
  2 in total

1.  Straightforward synthesis of various chiral pyrimidines bearing a stereogenic center adjacent to the C-2 position, including C-terminal peptide isosteres.

Authors:  Sami Sahtel; Chayma Ben Maamer; Rafâa Besbes; Emmanuel Vrancken; Jean-Marc Campagne
Journal:  Amino Acids       Date:  2022-10-13       Impact factor: 3.789

Review 2.  Synthesis of novel cyclopeptides containing heterocyclic skeletons.

Authors:  Fatima Hamdan; Fatemeh Tahoori; Saeed Balalaie
Journal:  RSC Adv       Date:  2018-10-03       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.